Posts tagged Amgen

Zacks Analyst Blog Highlights: Jinpan International, Whole Foods Market, Amgen, Novartis and Glaxo Smith Kline

0
1 year ago
by admin in

Zacks Analyst Blog Highlights: Jinpan International, Whole Foods Market, Amgen, Novartis and GlaxoSmithKline
Zacks Analyst Blog Highlights: Jinpan International, Whole Foods Market, Amgen, Novartis’ and GlaxoSmithKline

Read more on Zacks.com via Yahoo! Finance

Amgen drug cuts prostate cancer bone problems

0
1 year ago
by admin in

Amgen drug cuts prostate cancer bone problems
A third pivotal trial of Amgen Inc’s denosumab found that it significantly delayed the likelihood of suffering fractures and other bone complications in men with advanced prostate cancer compared with current therapy.

Read more on Reuters via Yahoo! News

Amgen climbed on osteoporosis drug approval

0
1 year ago
by admin in

Amgen climbs on osteoporosis drug approval
BOSTON (MarketWatch) — Shares of Amgen Inc. rose in early trading Wednesday, the morning after the biotech group announced that it has won U.S. regulatory approval for its drug Prolia for the treatment of osteoporosis in postmenopausal women. Amgen shares were up 6% at $53.84. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for …

Read more on Market Watch

Zacks Analyst Blog Highlights: Ford Motor, General Motors, Tata Motors, Amgen and Glaxo Smith Kline

0
1 year ago
by admin in

Zacks Analyst Blog Highlights: Ford Motor, General Motor, Tata Motors, Amgen and GlaxoSmithKline
Zacks Analyst Blog Highlights: Ford Motor, General Motor, Tata Motors, Amgen and GlaxoSmithKline

Read more on Zacks.com via Yahoo! Finance

Can Amgen rise to $80 a share?

0
1 year ago
by admin in

Can Amgen rise to $80 a share?
Can Amgen rise to $80 a share?

Read more on Khaleej Times

Earnings Roundup: Amgen first-quarter profit rises 15%

0
1 year ago
by admin in

Earnings Roundup: Amgen first-quarter profit rises 15%
The biotech drug maker warns healthcare legislation will hurt full-year results. Amgen Inc. said Wednesday that higher sales of its anti-infection drugs helped lift first-quarter profit by 15%, but the biotech drugmaker cautioned that healthcare reform measures will tamp down full-year results.

Read more on Los Angeles Times

Amgen Profit Rises as Drug Sales, Prices Increase (Update3)

0
1 year ago
by admin in

Amgen Profit Rises as Drug Sales, Prices Increase (Update3)
Amgen Inc., the world’s largest biotechnology company, said first-quarter profit climbed 15 percent as it boosted sales and prices on its drugs. Revenue for 2010 will be at the low end of previous forecasts due to costs of the U.S. health-care overhaul, the company said.

Read more on BusinessWeek

Amgen 1Q profit tops view; warns on reform costs

0
1 year ago
by admin in

Amgen 1Q profit tops view; warns on reform costs
Amgen Inc. said Wednesday that higher sales of its anti-infection drugs helped lift first-quarter profit by 15 percent, but the drugmaker cautioned that health care reform measures will tamp down full-year results.

Read more on AP via Yahoo! News

Go to Top